Linden Capital L.P. short positions
Current short positions and disclosure history reported by this institution.
Stocks held (0.5% or more)
1 stocks
11 stocks reported
Total position (shares)
1,595,762
Total of current positions
Last report
2026-09-11
Latest calculation date
Number of Stocks Held Weekly, positions of 0.5% or more
Number of stocks in which this institution reports a short position of 0.5% or more. Hover over (or tap) the chart to see the weekly count and total shares.
Current Positions Latest report for each stock
| Last report | Stock | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-09-11 | Nxera Pharma Co.,Ltd.4565 | Position 1,595,762 shares | Ratio 1.7200% | ▼0.1700% | Holding |
| 2024-09-06 | INFRONEER Holdings Inc.5076 | Position 1,335,966 shares | Ratio 0.4900% | ▼0.0101% | Below 0.5% |
| 2021-09-16 | HEALIOS K.K.4593 | Position 245,942 shares | Ratio 0.4800% | ▼0.0201% | Below 0.5% |
| 2026-03-03 | NIPPON STEEL CORPORATION5401 | Position 4,271,400 shares | Ratio 0.4500% | ▼0.2000% | Below 0.5% |
| 2020-01-21 | ONOKEN CO.,LTD.7414 | Position 94,093 shares | Ratio 0.4300% | ▼0.2100% | Below 0.5% |
| 2020-12-22 | YAOKO CO.,LTD8279 | Position 170,028 shares | Ratio 0.4300% | ▼0.1500% | Below 0.5% |
| 2021-02-05 | MARUWA UNYU KIKAN CO.,LTD.9090 | Position 299,932 shares | Ratio 0.2300% | ▼0.2801% | Below 0.5% |
| 2022-01-06 | giftee Inc.4449 | Position 58,950 shares | Ratio 0.2200% | ▼0.3700% | Below 0.5% |
| 2017-09-06 | Topre Corporation5975 | Position 0 shares | Ratio 0.0000% | ▼1.4000% | Closed |
| 2025-12-10 | NTN CORPORATION6472 | Position 0 shares | Ratio 0.0000% | ▼2.3800% | Closed |
| 2017-12-21 | PARAMOUNT BED HOLDINGS CO.,LTD.7817 | Position 0 shares | Ratio 0.0000% | ▼1.4000% | Closed |
Disclosure History Latest 100
| Trade date | Stock | Position (shares) | Ratio | Change | Short seller |
|---|---|---|---|---|---|
| 2026-09-11 | Nxera Pharma Co.,Ltd.4565 | Position 1,595,762 shares | Ratio 1.7200% | ▼0.1700% | Linden Capital L.P. |
| 2026-05-15 | Nxera Pharma Co.,Ltd.4565 | Position 1,730,947 shares | Ratio 1.8900% | ▼0.0501% | Linden Capital L.P. |
| 2026-05-11 | Nxera Pharma Co.,Ltd.4565 | Position 1,782,938 shares | Ratio 1.9400% | ▲0.1899% | Linden Capital L.P. |
| 2026-05-08 | Nxera Pharma Co.,Ltd.4565 | Position 1,604,520 shares | Ratio 1.7500% | ▲0.4099% | Linden Capital L.P. |
| 2026-04-24 | Nxera Pharma Co.,Ltd.4565 | Position 1,210,330 shares | Ratio 1.3400% | ▼0.1300% | Linden Capital L.P. |
| 2026-04-17 | Nxera Pharma Co.,Ltd.4565 | Position 1,328,632 shares | Ratio 1.4700% | ▼0.0401% | Linden Capital L.P. |
| 2026-04-16 | Nxera Pharma Co.,Ltd.4565 | Position 1,367,458 shares | Ratio 1.5100% | ▲0.0800% | Linden Capital L.P. |
| 2026-04-01 | Nxera Pharma Co.,Ltd.4565 | Position 1,289,325 shares | Ratio 1.4300% | ▲0.1399% | Linden Capital L.P. |
| 2026-03-16 | Nxera Pharma Co.,Ltd.4565 | Position 1,164,698 shares | Ratio 1.2900% | ▼0.0301% | Linden Capital L.P. |
| 2026-03-11 | Nxera Pharma Co.,Ltd.4565 | Position 1,201,798 shares | Ratio 1.3200% | ▲0.1000% | Linden Capital L.P. |
| 2026-03-03 | NIPPON STEEL CORPORATION5401 | Position 4,271,400 shares | Ratio 0.4500% | ▼0.2000% | Linden Capital L.P. |
| 2026-03-02 | NIPPON STEEL CORPORATION5401 | Position 6,219,600 shares | Ratio 0.6500% | ▼0.0900% | Linden Capital L.P. |
| 2026-02-27 | Nxera Pharma Co.,Ltd.4565 | Position 1,106,536 shares | Ratio 1.2200% | ▲0.0700% | Linden Capital L.P. |
| 2026-02-26 | NIPPON STEEL CORPORATION5401 | Position 7,040,800 shares | Ratio 0.7400% | ▼0.3900% | Linden Capital L.P. |
| 2026-02-25 | NIPPON STEEL CORPORATION5401 | Position 10,755,600 shares | Ratio 1.1300% | ▲0.9500% | Linden Capital L.P. |
| 2026-01-13 | Nxera Pharma Co.,Ltd.4565 | Position 1,048,156 shares | Ratio 1.1500% | ▼0.0501% | Linden Capital L.P. |
| 2026-01-07 | Nxera Pharma Co.,Ltd.4565 | Position 1,091,869 shares | Ratio 1.2000% | ▲0.0700% | Linden Capital L.P. |
| 2025-12-15 | Nxera Pharma Co.,Ltd.4565 | Position 1,023,248 shares | Ratio 1.0300% | ±0.0000% | Linden Capital L.P. |
| 2025-12-10 | NTN CORPORATION6472 | Position 0 shares | Ratio 0.0000% | ▼2.3800% | Linden Capital L.P. |
| 2025-12-02 | Nxera Pharma Co.,Ltd.4565 | Position 927,606 shares | Ratio 1.0300% | ▲0.0500% | Linden Capital L.P. |
| 2025-12-01 | Nxera Pharma Co.,Ltd.4565 | Position 886,714 shares | Ratio 0.9800% | ▲0.2300% | Linden Capital L.P. |
| 2025-11-28 | NTN CORPORATION6472 | Position 12,688,179 shares | Ratio 2.3800% | ▲0.1200% | Linden Capital L.P. |
| 2025-11-26 | NTN CORPORATION6472 | Position 12,019,343 shares | Ratio 2.2600% | ▲0.1799% | Linden Capital L.P. |
| 2025-11-20 | NTN CORPORATION6472 | Position 11,087,059 shares | Ratio 2.0800% | ▼0.0500% | Linden Capital L.P. |
| 2025-11-14 | NTN CORPORATION6472 | Position 11,342,252 shares | Ratio 2.1300% | ▲0.0899% | Linden Capital L.P. |
| 2025-11-10 | NTN CORPORATION6472 | Position 10,873,136 shares | Ratio 2.0400% | ▲0.1100% | Linden Capital L.P. |
| 2025-11-06 | NTN CORPORATION6472 | Position 10,278,102 shares | Ratio 1.9300% | ▲0.0799% | Linden Capital L.P. |
| 2025-11-04 | NTN CORPORATION6472 | Position 9,869,256 shares | Ratio 1.8500% | ▲0.2800% | Linden Capital L.P. |
| 2025-10-31 | NTN CORPORATION6472 | Position 8,374,283 shares | Ratio 1.5700% | ▼0.2901% | Linden Capital L.P. |
| 2025-10-30 | NTN CORPORATION6472 | Position 9,897,376 shares | Ratio 1.8600% | ▲0.0800% | Linden Capital L.P. |
| 2025-10-29 | NTN CORPORATION6472 | Position 9,473,175 shares | Ratio 1.7800% | ▼0.0301% | Linden Capital L.P. |
| 2025-10-29 | Nxera Pharma Co.,Ltd.4565 | Position 675,455 shares | Ratio 0.7500% | ▼0.1300% | Linden Capital L.P. |
| 2025-10-28 | NTN CORPORATION6472 | Position 9,617,807 shares | Ratio 1.8100% | ▲0.0700% | Linden Capital L.P. |
| 2025-10-24 | NTN CORPORATION6472 | Position 9,262,802 shares | Ratio 1.7400% | ▲0.1399% | Linden Capital L.P. |
| 2025-10-22 | NTN CORPORATION6472 | Position 8,551,484 shares | Ratio 1.6000% | ▲0.2200% | Linden Capital L.P. |
| 2025-10-21 | NTN CORPORATION6472 | Position 7,364,478 shares | Ratio 1.3800% | ▲0.1499% | Linden Capital L.P. |
| 2025-10-14 | NTN CORPORATION6472 | Position 6,543,927 shares | Ratio 1.2300% | ▼0.1001% | Linden Capital L.P. |
| 2025-10-06 | NTN CORPORATION6472 | Position 7,063,986 shares | Ratio 1.3300% | ▲0.0800% | Linden Capital L.P. |
| 2025-10-03 | NTN CORPORATION6472 | Position 6,641,366 shares | Ratio 1.2500% | ▲0.1499% | Linden Capital L.P. |
| 2025-09-26 | NTN CORPORATION6472 | Position 5,967,858 shares | Ratio 1.0600% | ±0.0000% | Linden Capital L.P. |
| 2025-09-26 | Nxera Pharma Co.,Ltd.4565 | Position 862,832 shares | Ratio 0.8800% | ▼0.0700% | Linden Capital L.P. |
| 2025-09-25 | NTN CORPORATION6472 | Position 5,653,934 shares | Ratio 1.0600% | ▲0.0800% | Linden Capital L.P. |
| 2025-09-24 | NTN CORPORATION6472 | Position 5,235,050 shares | Ratio 0.9800% | ▼0.1101% | Linden Capital L.P. |
| 2025-09-19 | Nxera Pharma Co.,Ltd.4565 | Position 862,832 shares | Ratio 0.9500% | ▲0.1300% | Linden Capital L.P. |
| 2025-09-08 | NTN CORPORATION6472 | Position 5,794,573 shares | Ratio 1.0900% | ▲0.9100% | Linden Capital L.P. |
| 2025-09-08 | Nxera Pharma Co.,Ltd.4565 | Position 741,679 shares | Ratio 0.8200% | ▲0.0499% | Linden Capital L.P. |
| 2025-06-20 | Nxera Pharma Co.,Ltd.4565 | Position 699,322 shares | Ratio 0.7700% | ▼0.0301% | Linden Capital L.P. |
| 2025-06-02 | Nxera Pharma Co.,Ltd.4565 | Position 725,264 shares | Ratio 0.8000% | ▲0.0300% | Linden Capital L.P. |
| 2025-05-12 | Nxera Pharma Co.,Ltd.4565 | Position 694,039 shares | Ratio 0.7700% | ▼0.1000% | Linden Capital L.P. |
| 2025-05-01 | Nxera Pharma Co.,Ltd.4565 | Position 781,112 shares | Ratio 0.8700% | ▲0.1400% | Linden Capital L.P. |
| 2025-04-04 | Nxera Pharma Co.,Ltd.4565 | Position 658,473 shares | Ratio 0.7300% | ▼0.1100% | Linden Capital L.P. |
| 2025-04-02 | Nxera Pharma Co.,Ltd.4565 | Position 753,848 shares | Ratio 0.8400% | ▼0.0801% | Linden Capital L.P. |
| 2025-03-13 | Nxera Pharma Co.,Ltd.4565 | Position 823,375 shares | Ratio 0.9200% | ▲0.0800% | Linden Capital L.P. |
| 2025-03-07 | Nxera Pharma Co.,Ltd.4565 | Position 757,339 shares | Ratio 0.9300% | ±0.0000% | Linden Capital L.P. |
| 2025-03-03 | Nxera Pharma Co.,Ltd.4565 | Position 839,224 shares | Ratio 0.9300% | ▲0.0500% | Linden Capital L.P. |
| 2025-02-20 | Nxera Pharma Co.,Ltd.4565 | Position 789,130 shares | Ratio 0.8800% | ▼0.0401% | Linden Capital L.P. |
| 2025-02-18 | Nxera Pharma Co.,Ltd.4565 | Position 828,780 shares | Ratio 0.9200% | ▼0.0300% | Linden Capital L.P. |
| 2025-02-18 | Nxera Pharma Co.,Ltd.4565 | Position 954,690 shares | Ratio 1.0600% | ▲0.1100% | Linden Capital L.P. |
| 2025-02-03 | Nxera Pharma Co.,Ltd.4565 | Position 854,125 shares | Ratio 0.9500% | ▼0.1201% | Linden Capital L.P. |
| 2025-01-14 | Nxera Pharma Co.,Ltd.4565 | Position 964,783 shares | Ratio 1.0700% | ▼0.1000% | Linden Capital L.P. |
| 2025-01-06 | Nxera Pharma Co.,Ltd.4565 | Position 1,048,506 shares | Ratio 1.1700% | ▼0.1001% | Linden Capital L.P. |
| 2024-12-17 | Nxera Pharma Co.,Ltd.4565 | Position 1,137,579 shares | Ratio 1.2700% | ▼0.1100% | Linden Capital L.P. |
| 2024-12-13 | Nxera Pharma Co.,Ltd.4565 | Position 1,242,139 shares | Ratio 1.3800% | ▼0.1001% | Linden Capital L.P. |
| 2024-11-18 | Nxera Pharma Co.,Ltd.4565 | Position 1,333,276 shares | Ratio 1.4800% | ▼0.0601% | Linden Capital L.P. |
| 2024-10-16 | Nxera Pharma Co.,Ltd.4565 | Position 1,386,401 shares | Ratio 1.5400% | ▼0.1500% | Linden Capital L.P. |
| 2024-10-02 | Nxera Pharma Co.,Ltd.4565 | Position 1,514,707 shares | Ratio 1.6900% | ▼0.1001% | Linden Capital L.P. |
| 2024-09-17 | Nxera Pharma Co.,Ltd.4565 | Position 1,609,881 shares | Ratio 1.7900% | ▼0.0601% | Linden Capital L.P. |
| 2024-09-06 | INFRONEER Holdings Inc.5076 | Position 1,335,966 shares | Ratio 0.4900% | ▼0.0101% | Linden Capital L.P. |
| 2024-09-06 | Nxera Pharma Co.,Ltd.4565 | Position 1,666,666 shares | Ratio 1.8500% | ▼0.0700% | Linden Capital L.P. |
| 2024-09-04 | Nxera Pharma Co.,Ltd.4565 | Position 1,729,646 shares | Ratio 1.9200% | ▼0.0801% | Linden Capital L.P. |
| 2024-08-30 | Nxera Pharma Co.,Ltd.4565 | Position 1,800,979 shares | Ratio 2.0000% | ▼0.1201% | Linden Capital L.P. |
| 2024-08-29 | Nxera Pharma Co.,Ltd.4565 | Position 1,909,856 shares | Ratio 2.1200% | ▼0.3301% | Linden Capital L.P. |
| 2024-08-20 | Nxera Pharma Co.,Ltd.4565 | Position 2,198,005 shares | Ratio 2.4500% | ▲0.0900% | Linden Capital L.P. |
| 2024-08-16 | INFRONEER Holdings Inc.5076 | Position 1,374,374 shares | Ratio 0.5000% | ▲0.0200% | Linden Capital L.P. |
| 2024-08-16 | Nxera Pharma Co.,Ltd.4565 | Position 2,125,734 shares | Ratio 2.3600% | ▲0.1199% | Linden Capital L.P. |
| 2024-08-14 | Nxera Pharma Co.,Ltd.4565 | Position 2,017,794 shares | Ratio 2.2400% | ▲0.1200% | Linden Capital L.P. |
| 2024-08-09 | INFRONEER Holdings Inc.5076 | Position 1,328,610 shares | Ratio 0.4800% | ▼0.0201% | Linden Capital L.P. |
| 2024-08-07 | INFRONEER Holdings Inc.5076 | Position 1,373,418 shares | Ratio 0.5000% | ▲0.0800% | Linden Capital L.P. |
| 2024-08-07 | Nxera Pharma Co.,Ltd.4565 | Position 1,906,102 shares | Ratio 2.1200% | ▲0.0700% | Linden Capital L.P. |
| 2024-08-06 | Nxera Pharma Co.,Ltd.4565 | Position 1,844,248 shares | Ratio 2.0500% | ▲0.0799% | Linden Capital L.P. |
| 2024-08-05 | INFRONEER Holdings Inc.5076 | Position 1,143,448 shares | Ratio 0.4200% | ▼0.1700% | Linden Capital L.P. |
| 2024-08-05 | Nxera Pharma Co.,Ltd.4565 | Position 1,765,125 shares | Ratio 1.9700% | ▼0.2501% | Linden Capital L.P. |
| 2024-08-02 | Nxera Pharma Co.,Ltd.4565 | Position 1,981,940 shares | Ratio 2.2200% | ▼0.1900% | Linden Capital L.P. |
| 2024-07-24 | Nxera Pharma Co.,Ltd.4565 | Position 2,159,335 shares | Ratio 2.4100% | ▲0.1100% | Linden Capital L.P. |
| 2024-06-27 | Nxera Pharma Co.,Ltd.4565 | Position 2,059,562 shares | Ratio 2.3000% | ▲0.0799% | Linden Capital L.P. |
| 2024-06-25 | Nxera Pharma Co.,Ltd.4565 | Position 1,981,752 shares | Ratio 2.2200% | ▲0.0300% | Linden Capital L.P. |
| 2023-06-15 | Sosei Group Corporation4565 | Position 2,580,975 shares | Ratio 3.1500% | ▼0.1300% | Linden Capital L.P. |
| 2022-06-01 | Sosei Group Corporation4565 | Position 1,020,277 shares | Ratio 1.2500% | ▼0.1400% | Linden Capital L.P. |
| 2022-01-21 | Sosei Group Corporation4565 | Position 1,134,236 shares | Ratio 1.4800% | ±0.0000% | Linden Capital L.P. |
| 2022-01-18 | Sosei Group Corporation4565 | Position 1,202,560 shares | Ratio 1.4800% | ▼0.0801% | Linden Capital L.P. |
| 2022-01-06 | Sosei Group Corporation4565 | Position 1,273,752 shares | Ratio 1.5600% | ▼0.1000% | Linden Capital L.P. |
| 2022-01-06 | giftee Inc.4449 | Position 58,950 shares | Ratio 0.2200% | ▼0.3700% | Linden Capital L.P. |
| 2022-01-04 | Sosei Group Corporation4565 | Position 1,350,306 shares | Ratio 1.6600% | ▼0.0401% | Linden Capital L.P. |
| 2021-12-23 | Sosei Group Corporation4565 | Position 1,387,453 shares | Ratio 1.7000% | ▲0.0500% | Linden Capital L.P. |
| 2021-12-15 | Sosei Group Corporation4565 | Position 1,347,202 shares | Ratio 1.6500% | ▼0.1001% | Linden Capital L.P. |
| 2021-12-01 | Sosei Group Corporation4565 | Position 1,430,103 shares | Ratio 1.7500% | ▲0.0900% | Linden Capital L.P. |
| 2021-12-01 | giftee Inc.4449 | Position 162,634 shares | Ratio 0.5900% | ▼0.0101% | Linden Capital L.P. |
| 2021-11-30 | giftee Inc.4449 | Position 165,256 shares | Ratio 0.6000% | ▲0.6000% | Linden Capital L.P. |
| 2021-11-26 | Sosei Group Corporation4565 | Position 1,350,589 shares | Ratio 1.6600% | ▲0.4299% | Linden Capital L.P. |
| 2021-11-24 | Sosei Group Corporation4565 | Position 998,563 shares | Ratio 1.2300% | ▲0.1599% | Linden Capital L.P. |